摘要
不稳定性心绞痛(unstable angina,UA)是介于稳定性心绞痛与急性心肌梗死之间的一组临床综合征,其治疗药物十分复杂,临床药学监护尤为重要。本文结合实例,对抗心肌缺血治疗、抗血小板与抗凝治疗、调脂稳定斑块治疗、合并其他疾病用药时等情况下的药学监护内容进行逐一讨论,以期为该疾病的临床药学工作提供思路,优化临床治疗方案设计,保障患者的用药安全。
Unstable angina（UA） is a common coronary heart disease with the clinical symptom situated between stable angina and acute myocardial infarction.For the complexity of its drug treatment,the clinical pharmaceutical care for patients with UA is very important.In this article,to further optimize the therapeutic project and ensure the safety of drug use,the contents of pharmaceutical care were discussed from the following four aspects respectively：undergoing anti-ischemia therapy,antiplatelet and anticoagulant therapy,lipid adjusting and plaque stabilizing therapy,and simultaneous therapy for some other disease.
出处
《中国药物应用与监测》
CAS
2011年第1期24-25,34,共3页
Chinese Journal of Drug Application and Monitoring
关键词
临床药师
药学监护
不稳定性心绞痛
Clinical pharmacist
Pharmaceutical care
Unstable angina
